2025 CGT Regulatory Outlook

As the cell and gene therapy landscape continues to rapidly evolve, with over 450 unique products in clinical development and 50 approvals expected by 2030, understanding the regulatory environment is crucial for stakeholders across the industry. Cell & Gene Live focused on the forward-looking perspectives on the regulatory landscape that will shape the future of cell and gene therapies. Watch now to hear what our distinguished speakers had to say on the matter.